Last updated: October 2026
A corneal dendrite — a branching, tree-like epithelial lesion — is one of the most pattern-recognition-dependent findings in ophthalmology. The classic teaching is "dendrite = herpes simplex," but a meaningful minority of dendritiform lesions are pseudo-dendrites with entirely different causes and treatments. Misdiagnosing a pseudo-dendrite as HSV (or vice versa) can delay correct treatment or, worse, worsen the underlying condition.
Rather than relying on inconsistent older terminology, HSV keratitis is now classified simply by which corneal layer is principally involved, since this directly determines treatment:
| Category | Key feature | Core treatment |
|---|---|---|
| Epithelial keratitis (dendritic / geographic) | Live viral replication in epithelium | Antiviral only |
| Stromal keratitis | Immune-mediated stromal inflammation, +/- necrosis | Antiviral + topical corticosteroid (steroid only after antiviral cover established) |
| Endothelial keratitis (disciform) | Endothelial inflammation with stromal/epithelial oedema, keratic precipitates, no significant anterior chamber reaction | Antiviral + topical corticosteroid |
These lesions look dendritiform but lack true terminal bulbs, tend to be more plaque-like or heaped-up, and — critically — do not respond to antivirals. Consider:
The single most useful bedside discriminator remains careful slit-lamp assessment for true terminal bulbs and corneal sensation testing — reduced sensation strongly favors true HSV.
| HEDS finding | Practice point |
|---|---|
| Topical steroids for stromal keratitis (with antiviral cover) | Faster resolution and fewer treatment failures |
| Oral acyclovir did not help active stromal keratitis or iritis on top of topical treatment (trend for iritis) | Use oral antivirals mainly for prophylaxis or when topical drugs are unsuitable |
| Oral acyclovir 400 mg twice daily for 12 months | Halved recurrences of any ocular HSV and of stromal keratitis: use after recurrent stromal disease or keratoplasty |
| Epithelial keratitis did not trigger stromal disease | Oral acyclovir during epithelial disease does not prevent later stromal keratitis |
| Oral valaciclovir and famciclovir | Effective alternatives with simpler dosing; ganciclovir 0.15% gel and trifluridine are topical options |
Sources for this update: Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease. N Engl J Med. 1998;339:300-306 | White ML, Chodosh J. Herpes simplex virus keratitis: a treatment guideline. AAO; 2014.
Key references: American Academy of Ophthalmology. Herpes Simplex Virus Keratitis: A Treatment Guideline. | Merck Manual Professional Edition, Herpes Simplex Keratitis. | UpToDate, Herpes simplex keratitis (last updated Jan 2025).
📘 Want the exam-ready deep dive? This topic is covered in iNotes 2027: Cornea and Refractive (Ophthalmology Postgraduate Exam Notes) — available on Kindle. See all my books.
Want to know more about treatment? Read about our Eye Department or book a consultation with Dr. Dhaval Patel.